Company said the disclosure was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Also Read: AstraZeneca Pharma gets CDSCO nod to import leukaemia drug Calquence 100 mg tabletsThe firm had reported a mixed consolidated performance for the December quarter, with profit easing sequentially and revenue declining, even as margins showed a marginal improvement on better cost control.
Company’s consolidated net profit declining 1.5% quarter-on-quarter to ₹256.7 crore in FY26, compared with ₹260.7 crore in the September quarter. On a year-on-year basis, profit rose nearly 10% from ₹234.1 crore in the corresponding quarter last year.
Shares of Gujarat State Petronet Ltd closed at ₹242.00 on the NSE on April 10, 2026, rising ₹1.63 or 0.68% during the session.
Also Read: Torrent Pharma’s Gujarat oncology plant inspection by USFDA concludes with zero observations
First Published: Apr 10, 2026 8:21 PM IS

